- Profile
- Personal Information
- Publications
Experts in Immunology
Priti Bajpai M.J.M. (MARC) BONTEN Rolee Sharma Douglas Darling Donald Demuth Alba Ruiz de Andrés Javier MartÃnez-Picado Prof. Sarat Kumar Dalai Prof. Sarat Kumar Dalai Julià Blanco Cezmi A. Akdis Dr Joanna Kirman Arianna Calcinotto Dennis W. McGee Liz Hedstrom Daniela Brina Joan Press Neil E. Simister Mausumi Sikdar (Nee Bhakta ) Asmita Das View MoreVanessa Malier is Managing Partner at Kurma Partners. Scientist by training, Vanessa joined the Paris based VC fund CDC-Innovation in 1998. After having held business development responsibilities in a California based biotech, Vanessa joined Ipsen in 2003, as Strategic Advisor to the CEO and headed the portfolio management team for the GI franchise (totaling circa 130M€). Vanessa was appointed in 2005 as Team Leader for febuxostat (Adenuric), which received EMA approval in 2008. Vanessa was then successively appointed as Sr Director, Business Development Oncology in 2009 and VP, R&D Strategic Planning in 2011. Vanessa graduated in Biology at Ecole Normale Superieure, Cachan and in Immunology at Pasteur Institute. Vanessa joined Kurma in September 2013. Vanessa has been a Director of Erytech (France) and is a Director of Xeltis (Switzerland), Step Pharma (France), Safe Orthopaedics (France) and Asceneuron (Switzerland).
Oncology Immunology